| Product Code: ETC12836172 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Netherlands Infectious Vaccines Market Overview |
3.1 Netherlands Country Macro Economic Indicators |
3.2 Netherlands Infectious Vaccines Market Revenues & Volume, 2021 & 2031F |
3.3 Netherlands Infectious Vaccines Market - Industry Life Cycle |
3.4 Netherlands Infectious Vaccines Market - Porter's Five Forces |
3.5 Netherlands Infectious Vaccines Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Netherlands Infectious Vaccines Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Netherlands Infectious Vaccines Market Revenues & Volume Share, By End-Use, 2021 & 2031F |
3.8 Netherlands Infectious Vaccines Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Netherlands Infectious Vaccines Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about the importance of vaccination for infectious diseases |
4.2.2 Government initiatives to promote vaccination programs |
4.2.3 Rising prevalence of infectious diseases in the Netherlands |
4.3 Market Restraints |
4.3.1 High cost associated with vaccine development and production |
4.3.2 Stringent regulatory requirements for vaccine approval |
4.3.3 Vaccine hesitancy and misinformation among the population |
5 Netherlands Infectious Vaccines Market Trends |
6 Netherlands Infectious Vaccines Market, By Types |
6.1 Netherlands Infectious Vaccines Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Netherlands Infectious Vaccines Market Revenues & Volume, By Type, 2021 - 2031F |
6.1.3 Netherlands Infectious Vaccines Market Revenues & Volume, By Live Attenuated Vaccines, 2021 - 2031F |
6.1.4 Netherlands Infectious Vaccines Market Revenues & Volume, By Inactivated Vaccines, 2021 - 2031F |
6.1.5 Netherlands Infectious Vaccines Market Revenues & Volume, By mRNA Vaccines, 2021 - 2031F |
6.2 Netherlands Infectious Vaccines Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Netherlands Infectious Vaccines Market Revenues & Volume, By COVID-19, 2021 - 2031F |
6.2.3 Netherlands Infectious Vaccines Market Revenues & Volume, By Influenza, 2021 - 2031F |
6.2.4 Netherlands Infectious Vaccines Market Revenues & Volume, By Hepatitis, 2021 - 2031F |
6.3 Netherlands Infectious Vaccines Market, By End-Use |
6.3.1 Overview and Analysis |
6.3.2 Netherlands Infectious Vaccines Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.3.3 Netherlands Infectious Vaccines Market Revenues & Volume, By Pharmacies, 2021 - 2031F |
6.3.4 Netherlands Infectious Vaccines Market Revenues & Volume, By Government Immunization Programs, 2021 - 2031F |
6.4 Netherlands Infectious Vaccines Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 Netherlands Infectious Vaccines Market Revenues & Volume, By Public Health Agencies, 2021 - 2031F |
6.4.3 Netherlands Infectious Vaccines Market Revenues & Volume, By Private Clinics, 2021 - 2031F |
7 Netherlands Infectious Vaccines Market Import-Export Trade Statistics |
7.1 Netherlands Infectious Vaccines Market Export to Major Countries |
7.2 Netherlands Infectious Vaccines Market Imports from Major Countries |
8 Netherlands Infectious Vaccines Market Key Performance Indicators |
8.1 Immunization coverage rates |
8.2 Disease incidence rates |
8.3 Research and development investment in infectious vaccines |
9 Netherlands Infectious Vaccines Market - Opportunity Assessment |
9.1 Netherlands Infectious Vaccines Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Netherlands Infectious Vaccines Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Netherlands Infectious Vaccines Market Opportunity Assessment, By End-Use, 2021 & 2031F |
9.4 Netherlands Infectious Vaccines Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Netherlands Infectious Vaccines Market - Competitive Landscape |
10.1 Netherlands Infectious Vaccines Market Revenue Share, By Companies, 2024 |
10.2 Netherlands Infectious Vaccines Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here